Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection

J Pharm Biomed Anal. 2008 Nov 4;48(3):951-4. doi: 10.1016/j.jpba.2008.05.022. Epub 2008 May 28.

Abstract

This paper describes the development and validation of a HPLC-UV method (210 nm) for the simultaneous quantitation of artemether and lumefantrine in fixed dose combination tablets. The method showed to be linear (r(2)>0.99), precise (R.S.D.<2.0%), accurate (recovery of 101.07% for artemether and 101.58% for lumefantrine), specific and robust. Four batches of artemether-lumefantrine tablets were assayed by the validated method. The artemether contents in the tablets varied from 98.61% to 103.35%, while lumefantrine contents were 97.92-100.48%.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / analysis*
  • Antimalarials / chemistry
  • Artemether
  • Artemisinins / analysis*
  • Artemisinins / chemistry
  • Chromatography, High Pressure Liquid / methods*
  • Dosage Forms
  • Drug Combinations
  • Ethanolamines / analysis*
  • Ethanolamines / chemistry
  • Fluorenes / analysis*
  • Fluorenes / chemistry
  • Lumefantrine
  • Molecular Structure
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet / methods*
  • Tablets / analysis

Substances

  • Antimalarials
  • Artemisinins
  • Dosage Forms
  • Drug Combinations
  • Ethanolamines
  • Fluorenes
  • Tablets
  • Artemether
  • Lumefantrine